Dr. Acosta is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Ave 359 De Diego
Fundacion De Investigacion De Diego
San Juan, PR 00927Phone+1 787-722-1248
Education & Training
- University of Puerto RicoFellowship, Hematology and Medical Oncology, 2011 - 2014
- University of Puerto RicoResidency, Internal Medicine, 2008 - 2011
- University of Puerto Rico School of MedicineClass of 2008
Certifications & Licensure
- PR State Medical License 2014 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 642 citationsEfficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib: The CheckMate 040 Randomized Cli...Thomas Yau, Yoon-Koo Kang, Tae-You Kim, Anthony B. El-Khoueiry, Armando Santoro
JAMA Oncology. 2020-11-01 - 22 citationsNivolumab Plus Cabozantinib With or Without Ipilimumab for Advanced Hepatocellular Carcinoma: Results From Cohort 6 of the CheckMate 040 Trial.Thomas Yau, Vittorina Zagonel, Armando Santoro, Mirelis Acosta-Rivera, Su Pin Choo
Journal of Clinical Oncology. 2023-03-20 - 123 citationsCheckMate 040 cohort 5: A phase I/II study of nivolumab in patients with advanced hepatocellular carcinoma and Child-Pugh B cirrhosis.Masatoshi Kudo, Ana Matilla, Armando Santoro, Ignacio Melero, Antonio Cubillo Gracian
Journal of Hepatology. 2021-05-26
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: